Please login to the form below

Not currently logged in
Email:
Password:

bortezomib

This page shows the latest bortezomib news and features for those working in and with pharma, biotech and healthcare.

J&J’s Darzalex shows ‘significant’ survival benefit in newly diagnosed multiple myeloma

J&J’s Darzalex shows ‘significant’ survival benefit in newly diagnosed multiple myeloma

However, Sanofi is currently evaluating Sarclisa in combination with Velcade (bortezomib), Revlimid and dexamethasone in newly diagnosed multiple myeloma patients who are not eligible for transplant.

Latest news

More from news
Approximately 5 fully matching, plus 93 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....